William M. Mitchell - 21 Apr 2025 Form 4 Insider Report for AIM ImmunoTech Inc. (AIMI)

Reporting relationship: Director
Issuer ticker: AIMI
Reported as of: 21 Apr 2025
Net transaction value: +$5,000
SEC form: 4
Accepted by SEC: 23 Apr 2025, 16:35:19 UTC
Prior SEC filing: 18 Mar 2025
Source filing: View source filing
Reporting owner signature: /s/ William M Mitchell

Key filing fact

William M. Mitchell filed Form 4 for AIM ImmunoTech Inc. (AIMI) on 23 Apr 2025.

Key facts

This page summarizes William M. Mitchell's Form 4 filing for AIM ImmunoTech Inc. (AIMI).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 23 Apr 2025, 16:35.

Change

Previous filing in this sequence was filed on 18 Mar 2025.
Current net transaction value: +$5,000.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

AIM transaction

Common Stock

Purchase

Transaction value: $5,000
Shares: +196,851
Change %: +61%
Price: $0.0254
Shares after: 521,723
Date: 11 Apr 2025
Ownership: Direct
Footnotes: F1

AIM holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 190
Date: 21 Apr 2025
Ownership: by Spouse

AIM holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 190
Date: 21 Apr 2025
Ownership: by Trusts

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Shares purchased pursuant to a purchase agreement executed on April 11, 2025, but first required approval from the NYSE American which was received on April 21, 2025.